Literature DB >> 15611610

Characterization of mechanisms of fluconazole resistance in a Candida albicans isolate from a Japanese patient with chronic mucocutaneous candidiasis.

Yasuki Kamai1, Kazunori Maebashi, Michinari Kudoh, Koichi Makimura, Wataru Naka, Katsuhisa Uchida, Hideyo Yamaguchi.   

Abstract

We examined the mechanisms of fluconazole resistance in a fluconazole-resistant Candida albicans isolate from a Japanese patient with chronic mucocutaneous candidiasis. It was demonstrated that the highly resistant phenotype of this strain was associated with combined mechanisms of the energy-dependent reduced intracellular accumulation of fluconazole, presumably due to the increased expression of the ATP-binding cassette efflux pump CDR gene(s), and the reduced affinity of the target enzyme, Erg11p, to fluconazole. In particular, the reduced affinity of Erg11p was considered to contribute largely to the fluconazole resistance in the TIMM3209 strain. Biochemical studies indicated that the Erg11p from the TIMM3209 strain showed reduced susceptibility both to fluconazole and itraconazole of cell-free ergosterol biosynthesis, and cytochrome P-450 also showed reduced affinity to fluconazole in the carbon monoxidecytochrome P-450 complex formation assay. We identified two amino acid substitutions, Y132H and G448V, in Erg11p from the TIMM3209 strain. We found that the cytochrome P-450 from the TIMM3209 strain decayed during incubation at 37 C without fluconazole although it is unknown whether or not the phenomenon is linked to the resistant phenotype. These mutations are thought to confer the above-mentioned characteristics to Erg11p.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15611610     DOI: 10.1111/j.1348-0421.2004.tb03623.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  6 in total

1.  Heterologous expression of mutated eburicol 14alpha-demethylase (CYP51) proteins of Mycosphaerella graminicola to assess effects on azole fungicide sensitivity and intrinsic protein function.

Authors:  H J Cools; J E Parker; D E Kelly; J A Lucas; B A Fraaije; S L Kelly
Journal:  Appl Environ Microbiol       Date:  2010-03-19       Impact factor: 4.792

2.  Impact of recently emerged sterol 14{alpha}-demethylase (CYP51) variants of Mycosphaerella graminicola on azole fungicide sensitivity.

Authors:  Hans J Cools; Jonathan G L Mullins; Bart A Fraaije; Josie E Parker; Diane E Kelly; John A Lucas; Steven L Kelly
Journal:  Appl Environ Microbiol       Date:  2011-04-08       Impact factor: 4.792

3.  Detection of ERG11 point mutations in Iranian fluconazole-resistant Candida albicans isolates.

Authors:  Ali Sardari; Hossein Zarrinfar; Rasoul Mohammadi
Journal:  Curr Med Mycol       Date:  2019-03

4.  Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.

Authors:  Peter G Pappas; Carol A Kauffman; David R Andes; Cornelius J Clancy; Kieren A Marr; Luis Ostrosky-Zeichner; Annette C Reboli; Mindy G Schuster; Jose A Vazquez; Thomas J Walsh; Theoklis E Zaoutis; Jack D Sobel
Journal:  Clin Infect Dis       Date:  2015-12-16       Impact factor: 9.079

5.  Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

Authors:  Peter G Pappas; Carol A Kauffman; David Andes; Daniel K Benjamin; Thierry F Calandra; John E Edwards; Scott G Filler; John F Fisher; Bart-Jan Kullberg; Luis Ostrosky-Zeichner; Annette C Reboli; John H Rex; Thomas J Walsh; Jack D Sobel
Journal:  Clin Infect Dis       Date:  2009-03-01       Impact factor: 9.079

Review 6.  Anti dermatophytic therapy--prospects for the discovery of new drugs from natural products.

Authors:  Luciana Arantes Soares; Janaína de Cássia Orlandi Sardi; Fernanda Patrícia Gullo; Nayla de Souza Pitangui; Liliana Scorzoni; Fernanda Sangalli Leite; Maria José Soares Mendes Giannini; Ana Marisa Fusco Almeida
Journal:  Braz J Microbiol       Date:  2014-03-10       Impact factor: 2.476

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.